Skip to main content

Currently Skimming:

Message from the Co-Chairs
Pages 2-5

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 2...
... new ideas and partnerships Clinical trials remain a cornerstone of medical product development by providing and offers a neutral space the scientific evidence that proves or disproves concepts developed during earlier for stakeholders to advance stages of development about the safety and efficacy of medical products and by critical policy discussions on informing clinical care. At the same time, the clinical research enterprise faces continued and mounting pressures, strained from all sides by rising costs, an biopharmaceutical innovation evolving regulatory and economic landscape, increasing clinical trial complexity, nationally and globally.
From page 3...
... In 2019, more work is needed to spur biomedical innovation in a responsible manner and to ensure that research is adequately powered to answer real questions about the safety and effectiveness of medical products. The executive and legislative branches of the federal government have continued to show bipartisan support for biomedical research, including ongoing funding for programs such as the BRAIN Initiative, the Precision Medicine Initiative, and the 21st Century Cures Act.
From page 4...
... Forum members at the 41st Forum meeting held in October 2018.
From page 5...
... Contents Reflecting Back: Forum Activities in 2018 6 Looking Forward: Forum Activities in 2019 11 Action Collaboratives 14 Forum Themes and Priorities 18 Forum Sponsorship and Membership 22 Timeline 24


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.